APA

Ballinger M. D., Shyamala V., Forrest L. D., Deuter-Reinhard M., Doyle L. V., Wang J. X., Panganiban-Lustan L., Stratton J. R., Apell G., Winter J. A., Doyle M. V., Rosenberg S. & Kavanaugh W. M. (20000110). Semirational design of a potent, artificial agonist of fibroblast growth factor receptors. : Nature biotechnology.

Chicago

Ballinger M D, Shyamala V, Forrest L D, Deuter-Reinhard M, Doyle L V, Wang J X, Panganiban-Lustan L, Stratton J R, Apell G, Winter J A, Doyle M V, Rosenberg S and Kavanaugh W M. 20000110. Semirational design of a potent, artificial agonist of fibroblast growth factor receptors. : Nature biotechnology.

Harvard

Ballinger M. D., Shyamala V., Forrest L. D., Deuter-Reinhard M., Doyle L. V., Wang J. X., Panganiban-Lustan L., Stratton J. R., Apell G., Winter J. A., Doyle M. V., Rosenberg S. and Kavanaugh W. M. (20000110). Semirational design of a potent, artificial agonist of fibroblast growth factor receptors. : Nature biotechnology.

MLA

Ballinger M D, Shyamala V, Forrest L D, Deuter-Reinhard M, Doyle L V, Wang J X, Panganiban-Lustan L, Stratton J R, Apell G, Winter J A, Doyle M V, Rosenberg S and Kavanaugh W M. Semirational design of a potent, artificial agonist of fibroblast growth factor receptors. : Nature biotechnology. 20000110.